IL6 and cancer: On the other hand, the IL-6/STAT3 pathway increases miR-92a and miR-18a expression by directly targeting its promoter, which resulted in the activation of the Wnt/β-catenin signaling pathway and the promotion of the stem-like phenotype of cancer cells [50,51].